The team’s breakthrough centers around a protein called PD-L1, which is known for its role in helping cancer cells evade immune detection.

Molecules that cause a constant renewal of cell vitality could treat or prevent diseases of aging, such as Alzheimer’s and Parkinson’s.

Israel’s Eximo has successfully completed a clinical trial of its laser system and unique catheters for treating peripheral artery disease, and after 100% successful Mexican and European trials a prostate cancer drug has now been approved by Israel’s Ministry of Health.